Imperial Brands Urges Complete Ban on Teen Market E-Cigarette Promotion

Regulations by 2FIRSTS.ai
Dec.14.2023
Imperial Brands Urges Complete Ban on Teen Market E-Cigarette Promotion
Imperial Brands urges UK officials to impose a "complete ban" on e-cigarette marketing to adolescents and strengthen regulations.

According to a report by Journalnow, Imperial Brands Plc is urging British public health officials to establish and implement a "complete ban" on the promotion of e-cigarettes to the teenage market. In addition, the company is also advocating for stronger regulations on the sale of e-cigarette products to individuals below the age of 18.

 

Empire Brand officially announced its stance in a public statement released on Wednesday. In the statement, the company expresses...

 

We share concerns with the government regarding the increasing usage rate of e-cigarette products among young people. We also reference the perspective of Sir Chris Whitty, Chief Medical Officer of the United Kingdom, who suggests that we should continue to encourage current smokers to transition to the use of e-cigarettes, which pose a lower risk. Furthermore, there is a call to prohibit the sale and promotion of e-cigarettes to children.

 

However, the Imperial brand also cautioned that supporting restrictions on e-cigarettes for teenagers, especially minors, does not imply endorsing similar bans on adults.

 

Specifically, if the sale of disposable e-cigarettes is indeed prohibited, it is very likely to lead to a portion of nicotine consumers reverting back to traditional cigarettes, reversing the positive health trend that the UK should be proud of.

 

The Imperial brand supports the imposition of fines on retailers who sell e-cigarettes to minors and rejects the requirement of a "retail license" for selling e-cigarettes to minors. The Imperial brand cited data indicating that the UK's commercial regulatory standards have seized over 2.5 million illegal e-cigarettes in the past three years.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
FDA Launches National Priority Review Program: Drugs Aligned with U.S. Priorities May Be Approved in as Little as One Month
The FDA has launched the Commissioner’s National Priority Voucher (CNPV) program, reducing the review time for certain drugs to as little as 1–2 months. While the program currently applies only to pharmaceuticals, it demonstrates the FDA’s capacity to reform its review pathways. Whether a similar mechanism could extend to tobacco products now appears to be a matter of timing and technical details.
Jun.18
European Tobacco Tax Surge: Some Products See Increases of Up to 258%
European Tobacco Tax Surge: Some Products See Increases of Up to 258%
European tobacco taxes are set to rise sharply, with some products facing increases of up to 258%. Authorities are also considering including e-cigarettes in the tax framework to strengthen anti-smoking policies, aiming to generate an additional €15.1 billion (about $17.5 billion) in tax revenue.
Jun.16 by 2FIRSTS.ai
Product | ELUX Unveils New ASTRA Vape with Large Display and 50,000 Puffs
Product | ELUX Unveils New ASTRA Vape with Large Display and 50,000 Puffs
Vape brand ELUX unveiled its new product, ASTRA, at the World Vape Show Dubai 2025. The device features up to 50,000 puffs, a 1000mAh battery, and a circular display. ELUX ASTRA is not yet available for online purchase.
Jul.23 by 2FIRSTS.ai
German Customs Seize 3.3 Tons of Illegal E-Cigarettes, Causing Estimated $290,000 Tax Loss
German Customs Seize 3.3 Tons of Illegal E-Cigarettes, Causing Estimated $290,000 Tax Loss
German customs seized 3.3 tons of illegal e-cigarettes from a Dutch truck, involving over 753 liters of e-liquid. The driver and company owner face criminal charges. Estimated tax loss exceeds €245,000 ($290,000). Since July 2022, nicotine e-liquids in Germany are taxed at €0.26/ml.
Jul.25 by 2FIRSTS.ai
Product | Dual Magnetic Design and Top Display: JNR Aurora Debuts in the UK Market
Product | Dual Magnetic Design and Top Display: JNR Aurora Debuts in the UK Market
E-cigarette brand JNR has unveiled its new Aurora device, featuring a “2+10” pod system with a total capacity of 30,000 puffs and a top-mounted smart display. The product has been registered with the UK’s MHRA and officially launched in the UK market, retailing at approximately £11.99.
Jul.11 by 2FIRSTS.ai
 Correction and Apology Regarding Two Erroneous Reports
Correction and Apology Regarding Two Erroneous Reports
Jun.27